Literature DB >> 3216240

Epidemiology and risk of hypertension in the elderly: the Framingham Study.

P S Vokonas1, W B Kannel, L A Cupples.   

Abstract

The contribution of hypertension to the development of cardiovascular disease in older subjects of the Framingham Study was systematically examined. Because of its high prevalence and sustained impact as age increases, hypertension emerged as the dominant risk factor for cardiovascular disease in older persons. The prevalence of definite hypertension increased with age to include about 40% of older men and 50% of older women in the Framingham cohort. The total incidence of cardiovascular disease rose progressively with increasing systolic blood pressure, irrespective of age and sex. Risk in the elderly of both sexes was approximately twice as great as that observed for younger persons at the same levels of systolic blood pressure. The risk of cardiovascular disease rose proportionally with increasing diastolic blood pressure in older men; however, this trend was blunted in older women. These findings suggest a more consistent role for systolic blood pressure as a predictor of cardiovascular disease in older persons. When individuals were classified according to hypertensive status, the overall risk for cardiovascular events and deaths due to cardiovascular disease was two to three times higher in subjects with definite hypertension compared with normotensives for all age and sex groups considered. Again, the risk was two to three times higher in older persons and nearly always higher in men than in women. Thus, whether predominantly systolic or diastolic, hypertension is clearly dangerous in terms of both absolute and relative risk as well as risk gradients for a broad spectrum of cardiovascular disease events in the elderly.

Entities:  

Mesh:

Year:  1988        PMID: 3216240

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  42 in total

1.  Cardiovascular disease: risk factors in older Canadians.

Authors:  D R MacLean
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

2.  Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.

Authors:  Roberto Antonicelli; Stefano Omboni; Di Ciò Giovanni; Roberto Ansuini; Alfredo Mori; Rosaria Gesuita; Gianfranco Parati; Enrico Paciaroni
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 3.  Cardiovascular drug therapy in the elderly: benefits and challenges.

Authors:  Jerome L Fleg; Wilbert S Aronow; William H Frishman
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

4.  Variation between studies in reported relative risks associated with hypertension: time trends and other explanatory variables.

Authors:  P J Marang-van de Mheen; L J Gunning-Schepers
Journal:  Am J Public Health       Date:  1998-04       Impact factor: 9.308

5.  Predictors of mortality in very old subjects aged 80 years or over.

Authors:  E Casiglia; P Spolaore; G Ginocchio; G Colangeli; G Di Menza; M Marchioro; A Mazza; G B Ambrosio
Journal:  Eur J Epidemiol       Date:  1993-11       Impact factor: 8.082

6.  Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992.

Authors:  S A Kirkland; D R MacLean; D B Langille; M R Joffres; K M MacPherson; P Andreou
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

7.  Intake of trans fat and incidence of stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Authors:  James N Kiage; Peter D Merrill; Suzanne E Judd; Ka He; Loren Lipworth; Mary Cushman; Virginia J Howard; Edmond K Kabagambe
Journal:  Am J Clin Nutr       Date:  2014-02-12       Impact factor: 7.045

Review 8.  Prognosis in elderly hypertensive patients.

Authors:  E D Freis
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

Review 9.  Physiological changes due to age. Implications for cardiovascular drug therapy.

Authors:  I Stolarek; P J Scott; F I Caird
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

Review 10.  Choosing the optimum therapy for older hypertensive patients.

Authors:  W H Birkenhäger
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.